SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (42326)5/27/1999 9:19:00 PM
From: DlphcOracl  Read Replies (2) of 120523
 
Re: Medtronic (MDT)

The MDT CEO was just interviewed this evening on CNBC; FWIW, he was quite upbeat about the rate and success with which MDT has integrated its recent mergers/acquisions and about outlook for the rest of year. The acquisitions have been integrated smoothly, ahead of schedule, and MDT has a nice pipeline of new products it will introduce later this year. MDT is well off its YTD high as it has suffered from a bad case of "indigestion" while swallowing a number of large companies a bit too quickly. However, MDT has an extremely sharp management team and its recent acquisitons were quite astute. It positions MDT into several profitable and rapidly growing areas in the medical device realm that were not previously in its oeuvre with little overlap or duplication with its core coronary stent/pacemaker business. I believe MDT will emerge as an 800-lb gorilla in the health care sector.

Because of the vagaries of government interference and meddling,
I almost never invest in the medical/health care sector aside from an
occasional pharmaceutical stock. MDT is one of the rare exceptions to this rule.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext